Novartis nearly doubled its Endocyte bid during drawn-out courtship
The escalation in per-share price—which far exceeds that of other recent deals involving Indiana public companies—reflects the unique nature of M&A in the pharmaceutical realm.
Share prices
Calumet Specialty’s new CEO giving it second lease on life
Calumet shares now trade around $6.65, nearly double their October 2016 low but way down from October 2015, when they fetched around $27.
Finish Line’s merger with British suitor could pose challenge to Foot Locker
Combining Indianapolis-based Finish Line Inc. and JD Sports Fashion from across the pond could create a firm within striding distance of the sports apparel industry’s heavyweight, according to an analyst.
Carson’s parent ponders bankruptcy as part of restructuring
The comeback strategy for Bon-Ton Stores includes closing a dozen Carson’s stores, although Bon-Ton hasn’t specified locations. The only Carson’s in Indianapolis is the lone anchor for Circle Centre mall.
Analysts, investors laud Anthem’s new CEO, but reasons for turnover remain unclear
Stock analysts hailed Gail Boudreaux as an experienced, proven insurance executive, but some wondered why the company rolled out a succession move on such short notice.
Indy-based renewable energy firm to go public in merger worth up to $345M
IEA Energy Services has completed about 200 wind and solar projects around the country, including the 9,000-acre Benton County Wind Farm in northern Indiana.
Merchants Bancorp shares rise in trading debut after IPO
The Carmel-based bank raised $100 million, which it plans to use for a new acquisition and to further fuel growth.
Lilly shares slide on news of possible sale, spinoff of Elanco
Despite slipping sales and lost market share, the Elanco animal-health unit is strong and the time is right to explore selling or spinning it off, Eli Lilly and Co. officials said Tuesday.
Express Scripts to buy medical test gatekeeper for $3.6B
The deal comes as Express Scripts faces challenges on a number of fronts, including the possible loss of its largest customer, Indianapolis-based health-insurance giant Anthem Inc.
Battered Finish Line ripe for takeover
The Finish Line Inc. is highly vulnerable to being acquired, retail analysts say, thanks to a succession of challenges hitting it all at once.
Stock skids at Lids’ parent firm after company whacks outlook
Zionsville-based Lids Sports Group posted disappointing sales in its second quarter, mirroring recent results from other athletic apparel retailers. Its parent company is trying to dampen expectations for the overall firm.
Investors willing to bet on Angie’s List-HomeAdvisor combo as stock surges
A week after the announced acquisition of Angie's List, its shares are trading 38 percent above the offer price—signaling optimism about the forthcoming public company combining Angie's List and HomeAdvisor.
Other suitors will have chance to outbid HHGregg’s proposed buyer
The Indianapolis-based appliance and electronics retailer says it has interest from dozens of potential purchasers.
Despite $329M loss last year, Calumet looks ahead with ‘cautious optimism’
The Indianapolis-based company said it has seen positive results from efficiency and cost-cutting actions it took in 2016.
Stumbling HHGregg shares face delisting from stock exchange
The New York Stock Exchange has notified HHGregg that the company’s stock price needs rise above avoid a delisting. Its market cap also needs a boost.
UPDATE: Stonegate Mortgage to be acquired by Michigan firm for $211M
The deal would mark the end of Indianapolis-based Stonegate’s stint as a public company, which has largely disappointed investors since its IPO in 2013.
Indiana bank stocks surge on Trump prospects
Indiana-based banks have benefited from a post-election stock jolt hitting financial stocks across the country.
Angie’s List CEO says timing right to consider suitors
CEO Scott Durchslag said Tuesday the company wants to be proactive instead of reactive when it comes to courting suitors, a stark shift from his tone about the matter last year. Also, the company is gearing up to slash jobs in a cost-cutting effort.
Wall Street analysts jumping on Lilly train
For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.
Finish Line’s supply chain woes under control, CEO says
Sales and profit for the apparel seller’s most recent quarter either met or exceeding Wall Street’s expectations. It’s now embarking on a plan for responding to clothing trends more quickly.